Lisa Mullett is General Manager of Sunovion Pharmaceuticals Canada Inc., a subsidiary of Sunovion Pharmaceuticals Inc., a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. She guides the organization’s overall business strategy in Canada and leads the cross-functional team responsible for driving the growth of products in the Canada market portfolio.
Ms. Mullett has over 25 years of pharmaceutical industry experience including senior leadership roles in Canadian, U.S. and global markets spanning sales and marketing, strategy and planning, government affairs, business development and new product planning across multiple therapeutic areas.
She joined the organization in 2008 and held roles of increasing responsibility including Director of Hospital Products, Director of Marketing and Director of the Central Nervous System (CNS) Business Unit in Canada.
From 2017 to 2019 at the Sunovion Pharmaceuticals Inc. corporate headquarters in the U.S., Ms. Mullett provided strategic expertise and guidance as Senior Director, Commercial Strategy & Planning, Chief of Staff to the Chief Commercial Officer and Executive Director, New Product Planning.
Ms. Mullett holds a Bachelor of Arts degree in Administrative and Commercial Studies from the University of Western Ontario.